Aqr Capital Management LLC Morphic Holding, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $205,535 - $572,571	-9,636 Reduced 49.91%	9,669 $221,000
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $662,740 - $1.2 Million	19,305 New	19,305 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $792,316 - $1.2 Million	-18,311 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $359,562 - $452,722	6,707 Added 57.8%	18,311 $1.04 Million
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $27,348 - $39,383	606 Added 5.51%	11,604 $666,000

Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $327,410 - $933,180	10,998 New	10,998 $696,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.